Clinical Outcomes With A New Monofocal Intraocular Lens
Published 2022
- 40th Congress of the ESCRS
Reference: PP18.08
| Type: Free paper
| DOI:
10.82333/5599-0909
Authors:
Dipak Parmar* 1
, David Teenan 1
, Jan Venter 1
, Stephen Hannan 1
1Optical Express,Glasgow,United Kingdom
Purpose
To report on the safety and efficacy outcomes of the new TECNIS Eyhance ICB00 monofocal IOL with enhanced features for intermediate vision.
Setting
Private Refractive Surgery (Optical Express)
Methods
Outcomes of 1963 eyes from 1089 presbyopic patients who underwent cataract surgery or refractive lens exchange with bilateral implantation of the TECNIS Eyhance ICB00 were reviewed. The age range of patients was 36 to 92 years. Postoperative clinical safety and efficacy outcomes up to 12 months following implant were analysed.
Results
The mean binocular distance visual acuity was +0.01 logMAR (range -0.18 to +0.90 logMAR) and the mean binocular intermediate visual acuity was +0.09 logMAR (range -0.30 to 0.88 logMAR). Mean gain in visual acuity lines was 6 for UCDVA and 6 for UCIVA. Less than 5% of patients experienced severe difficulty with glare, halo or starburst. Less than 1% of patients reported significant difficulties with tasks requiring intermediate vision (e.g. working on computer, cooking, fixing things around house). The rate of postoperative adverse events related to the IOL remains low and comparable to other premium IOLs.
Conclusions
Outcomes of a large sample in a private refractive clinic setting suggest this new monofocal IOL is a good alternative for patients with ocular pathology where a multifocal IOL might be contraindicated. Thus far, the IOL showed low incidence of visual phenomena and complications within the first year.